A Dutch study on the use of Lidocaine in post-COVID was published in December 2025 in eClinicalMedicineThis research has received a lot of media attention.
C-support believes it's crucial to conduct research into potential treatments for post-COVID and other post-infectious conditions. At the same time, it's essential that these initial signs are investigated further and more specifically to ensure they can be used safely and effectively for patients. This type of research gives us an idea of what's possible, and that's an important first step. However, based on this, we don't yet know for sure whether it will actually prove helpful. Therefore, it currently doesn't provide sufficient insight into its practical applicability for patient care.
The post-COVID patient organizations have drafted a joint response to this research: you can read the response here.
